{"transactions":[{"id":737592,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38098,"kind":"person","name":"HOLMES EDWARD W","position":1,"cik":"0001197099","reported_name":"HOLMES EDWARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-15T21:02:14.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":7.3,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000829","document":"e665584_4-holmes.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197099/000119380526000829/e665584_4-holmes.xml","form_type":"4"}},{"id":737601,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-15T21:01:54.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":7.3,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000828","document":"e665583_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380526000828/e665583_4-farrell.xml","form_type":"4"}},{"id":737595,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38101,"kind":"person","name":"BARLOW JAMES F","position":1,"cik":"0001190637","reported_name":"BARLOW JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-15T21:01:35.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":7.3,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000827","document":"e665582_4-barlow.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190637/000119380526000827/e665582_4-barlow.xml","form_type":"4"}},{"id":737362,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":30083,"kind":"person","name":"Markels John","position":1,"cik":"0001803424","reported_name":"Markels John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-15T21:01:18.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":7.3,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000826","document":"e665581_4-markels.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380526000826/e665581_4-markels.xml","form_type":"4"}},{"id":737378,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-15T21:00:59.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":7.3,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000825","document":"e66580_4-slaoui.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712369/000119380526000825/e66580_4-slaoui.xml","form_type":"4"}},{"id":737414,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-15T21:00:35.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":7.3,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000824","document":"e665579_4-marquet.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000119380526000824/e665579_4-marquet.xml","form_type":"4"}},{"id":737358,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38014,"kind":"person","name":"Marantz Jing L.","position":1,"cik":"0001834528","reported_name":"Marantz Jing L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-15T21:00:21.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":7.3,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000823","document":"e665578_4-jing.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380526000823/e665578_4-jing.xml","form_type":"4"}},{"id":788348,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-05-07T20:32:54.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on May 1, 2027, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":100000,"derivative":{"exercise_price":8.63,"expiration_date":"2036-05-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193805-26-000578","document":"e665445_4-mulroy.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000119380526000578/e665445_4-mulroy.xml","form_type":"4"}},{"id":961739,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71070,"kind":"person","name":"Roberts Joseph","position":1,"cik":"0002101782","reported_name":"Roberts Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-19T22:22:23.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":10000,"derivative":{"exercise_price":6.52,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-25-001767","document":"e665069_4-roberts.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380525001767/e665069_4-roberts.xml","form_type":"4"}},{"id":961738,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-19T22:20:50.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":54000,"derivative":{"exercise_price":6.52,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001193805-25-001764","document":"e665058_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380525001764/e665058_4-kurata.xml","form_type":"4"}},{"id":961747,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-19T17:21:54.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":54000,"derivative":{"exercise_price":6.52,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001193805-25-001766","document":"e665060_4-chivukula.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380525001766/e665060_4-chivukula.xml","form_type":"4"}},{"id":961748,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-19T17:21:26.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":175000,"derivative":{"exercise_price":6.52,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001193805-25-001765","document":"e665059_4-payne.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000119380525001765/e665059_4-payne.xml","form_type":"4"}},{"id":1060019,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":76273,"kind":"person","name":"SASSINE ANDY","position":1,"cik":"0001515322","reported_name":"SASSINE ANDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T16:01:44.000Z","date":"2025-08-15","kind":"purchase","planned":false,"acquired":true,"shares":1238,"price":16.558,"value":20498.804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase reported on this Form 4 was effected by the Reporting Person pursuant to the Arcturus Therapeutics Holdings Inc. 2020 Employee Stock Purchase Plan (the \"ESPP\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 15, 2025."}],"balance_after":221764,"source":{"system":"sec-edgar","filing":"0001193805-25-001215","document":"e664797_4a-sassine.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515322/000119380525001215/e664797_4a-sassine.xml","form_type":"4/A","original_submission_date":"2025-08-19"}},{"id":1061405,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":76273,"kind":"person","name":"SASSINE ANDY","position":1,"cik":"0001515322","reported_name":"SASSINE ANDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T16:05:30.000Z","date":"2025-08-15","kind":"purchase","planned":false,"acquired":false,"shares":1238,"price":16.558,"value":20498.804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase reported on this Form 4 was effected by the Reporting Person pursuant to the Arcturus Therapeutics Holdings Inc. 2020 Employee Stock Purchase Plan (the \"ESPP\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 15, 2025."}],"balance_after":221764,"source":{"system":"sec-edgar","filing":"0001193805-25-001212","document":"e664791_4-sassine.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515322/000119380525001212/e664791_4-sassine.xml","form_type":"4"}},{"id":1114722,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-12T00:02:07.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":12.54,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-25-000878","document":"e664624_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380525000878/e664624_4-farrell.xml","form_type":"4"}},{"id":1114551,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-12T00:01:48.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":12.54,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-25-000877","document":"e664623_4-slaoui.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712369/000119380525000877/e664623_4-slaoui.xml","form_type":"4"}},{"id":1114564,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-12T00:01:31.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":12.54,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-25-000876","document":"e664622_4-marquet.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000119380525000876/e664622_4-marquet.xml","form_type":"4"}},{"id":1114531,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":30083,"kind":"person","name":"Markels John","position":1,"cik":"0001803424","reported_name":"Markels John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-12T00:01:12.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":12.54,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-25-000875","document":"e664621_4-markels.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380525000875/e664621_4-markels.xml","form_type":"4"}},{"id":1114529,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38014,"kind":"person","name":"Marantz Jing L.","position":1,"cik":"0001834528","reported_name":"Marantz Jing L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-12T00:00:54.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":12.54,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-25-000874","document":"e664620_4-jing.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380525000874/e664620_4-jing.xml","form_type":"4"}},{"id":1114723,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38101,"kind":"person","name":"BARLOW JAMES F","position":1,"cik":"0001190637","reported_name":"BARLOW JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-12T00:00:37.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":12.54,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-25-000873","document":"e664619_4-barlow.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190637/000119380525000873/e664619_4-barlow.xml","form_type":"4"}},{"id":1114719,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38098,"kind":"person","name":"HOLMES EDWARD W","position":1,"cik":"0001197099","reported_name":"HOLMES EDWARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-12T00:00:17.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":12.54,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-25-000872","document":"e664618_4-holmes.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197099/000119380525000872/e664618_4-holmes.xml","form_type":"4"}},{"id":1326107,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-18T21:07:29.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":60000,"derivative":{"exercise_price":16.24,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193805-24-001493","document":"e664086_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524001493/e664086_4-kurata.xml","form_type":"4"}},{"id":1326126,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-18T16:06:59.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":196000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":196000,"derivative":{"exercise_price":16.24,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":196000},"source":{"system":"sec-edgar","filing":"0001193805-24-001492","document":"e664085_4-payne.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000119380524001492/e664085_4-payne.xml","form_type":"4"}},{"id":1326125,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-18T16:06:26.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":60000,"derivative":{"exercise_price":16.24,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193805-24-001491","document":"e664084_4-chivukula.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524001491/e664084_4-chivukula.xml","form_type":"4"}},{"id":1326316,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":76273,"kind":"person","name":"SASSINE ANDY","position":1,"cik":"0001515322","reported_name":"SASSINE ANDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-18T16:06:07.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":60000,"derivative":{"exercise_price":16.24,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193805-24-001490","document":"e664083_4-sassine.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515322/000119380524001490/e664083_4-sassine.xml","form_type":"4"}},{"id":1385656,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2024-10-16T21:05:50.000Z","date":"2024-10-15","kind":"sale","planned":true,"acquired":false,"shares":12000,"price":20.7601,"value":249121.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 12,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on October 15, 2024, with sale prices ranging from $20.03 to $21.12 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":435334,"source":{"system":"sec-edgar","filing":"0001193805-24-001248","document":"e663956_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524001248/e663956_4-chivukula.xml","form_type":"4"}},{"id":1471647,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-22T01:30:44.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":14794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the annual grant to the Reporting Person as a member of the Board, prorated based on the date the Reporting Person was appointed to the Board."}],"balance_after":14794,"derivative":{"exercise_price":25.96,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":14794},"source":{"system":"sec-edgar","filing":"0001193805-24-000836","document":"e663735_4-jing.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712369/000119380524000836/e663735_4-jing.xml","form_type":"4"}},{"id":1471646,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-22T01:30:44.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a two year period from the date of grant. This represents the initial grant to the Reporting Person as a member of the Board of Directors."}],"balance_after":15000,"derivative":{"exercise_price":25.96,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000836","document":"e663735_4-jing.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712369/000119380524000836/e663735_4-jing.xml","form_type":"4"}},{"id":1474403,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38014,"kind":"person","name":"Marantz Jing L.","position":1,"cik":"0001834528","reported_name":"Marantz Jing L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-19T01:01:30.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":31,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000829","document":"e663730_4-jing.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000829/e663730_4-jing.xml","form_type":"4"}},{"id":1474402,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38014,"kind":"person","name":"Marantz Jing L.","position":1,"cik":"0001834528","reported_name":"Marantz Jing L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-19T01:01:30.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-24-000829","document":"e663730_4-jing.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000829/e663730_4-jing.xml","form_type":"4"}},{"id":1474401,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38014,"kind":"person","name":"Marantz Jing L.","position":1,"cik":"0001834528","reported_name":"Marantz Jing L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:01:30.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":3131,"source":{"system":"sec-edgar","filing":"0001193805-24-000829","document":"e663730_4-jing.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000829/e663730_4-jing.xml","form_type":"4"}},{"id":1474927,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38098,"kind":"person","name":"HOLMES EDWARD W","position":1,"cik":"0001197099","reported_name":"HOLMES EDWARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-19T01:01:13.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":31,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000828","document":"e663729_4-holmes.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197099/000119380524000828/e663729_4-holmes.xml","form_type":"4"}},{"id":1474926,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38098,"kind":"person","name":"HOLMES EDWARD W","position":1,"cik":"0001197099","reported_name":"HOLMES EDWARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-19T01:01:13.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-24-000828","document":"e663729_4-holmes.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197099/000119380524000828/e663729_4-holmes.xml","form_type":"4"}},{"id":1474925,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38098,"kind":"person","name":"HOLMES EDWARD W","position":1,"cik":"0001197099","reported_name":"HOLMES EDWARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:01:13.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":3131,"source":{"system":"sec-edgar","filing":"0001193805-24-000828","document":"e663729_4-holmes.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197099/000119380524000828/e663729_4-holmes.xml","form_type":"4"}},{"id":1474400,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":30083,"kind":"person","name":"Markels John","position":1,"cik":"0001803424","reported_name":"Markels John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-19T01:00:59.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":31,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000827","document":"e663728_4-markels.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000827/e663728_4-markels.xml","form_type":"4"}},{"id":1474399,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":30083,"kind":"person","name":"Markels John","position":1,"cik":"0001803424","reported_name":"Markels John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-19T01:00:59.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-24-000827","document":"e663728_4-markels.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000827/e663728_4-markels.xml","form_type":"4"}},{"id":1474398,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":30083,"kind":"person","name":"Markels John","position":1,"cik":"0001803424","reported_name":"Markels John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:00:59.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":3131,"source":{"system":"sec-edgar","filing":"0001193805-24-000827","document":"e663728_4-markels.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000827/e663728_4-markels.xml","form_type":"4"}},{"id":1474574,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-19T01:00:43.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":31,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000826","document":"e663727_4-marquet.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000119380524000826/e663727_4-marquet.xml","form_type":"4"}},{"id":1474573,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-19T01:00:43.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-24-000826","document":"e663727_4-marquet.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000119380524000826/e663727_4-marquet.xml","form_type":"4"}},{"id":1474572,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:00:43.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":3131,"source":{"system":"sec-edgar","filing":"0001193805-24-000826","document":"e663727_4-marquet.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000119380524000826/e663727_4-marquet.xml","form_type":"4"}},{"id":1474936,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38101,"kind":"person","name":"BARLOW JAMES F","position":1,"cik":"0001190637","reported_name":"BARLOW JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-19T01:00:27.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":31,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000825","document":"e663726_4-barlow.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190637/000119380524000825/e663726_4-barlow.xml","form_type":"4"}},{"id":1474935,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38101,"kind":"person","name":"BARLOW JAMES F","position":1,"cik":"0001190637","reported_name":"BARLOW JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-19T01:00:27.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-24-000825","document":"e663726_4-barlow.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190637/000119380524000825/e663726_4-barlow.xml","form_type":"4"}},{"id":1474934,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38101,"kind":"person","name":"BARLOW JAMES F","position":1,"cik":"0001190637","reported_name":"BARLOW JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:00:27.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":13131,"source":{"system":"sec-edgar","filing":"0001193805-24-000825","document":"e663726_4-barlow.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190637/000119380524000825/e663726_4-barlow.xml","form_type":"4"}},{"id":1474941,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-19T01:00:10.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":31,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000824","document":"e663725_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380524000824/e663725_4-farrell.xml","form_type":"4"}},{"id":1474940,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-19T01:00:10.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-24-000824","document":"e663725_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380524000824/e663725_4-farrell.xml","form_type":"4"}},{"id":1474939,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:00:10.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":55741,"source":{"system":"sec-edgar","filing":"0001193805-24-000824","document":"e663725_4-farrell.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380524000824/e663725_4-farrell.xml","form_type":"4"}},{"id":1478601,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":76273,"kind":"person","name":"SASSINE ANDY","position":1,"cik":"0001515322","reported_name":"SASSINE ANDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-14T16:06:11.000Z","date":"2024-06-12","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":32.03,"value":1601500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected in open market transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 50,000 shares of common stock of Arcturus Therapeutics Holdings Inc. (the \"Issuer\") sold by the Reporting Person in multiple transactions on June 12, 2024, with sales prices ranging from $31.52 to $33.54 per share. The Reporting Person undertakes to provide, upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":220526,"source":{"system":"sec-edgar","filing":"0001193805-24-000801","document":"e663716_4-sassine.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515322/000119380524000801/e663716_4-sassine.xml","form_type":"4"}},{"id":1486046,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2024-06-07T17:01:02.000Z","date":"2024-06-05","kind":"sale","planned":true,"acquired":false,"shares":114,"price":45,"value":5130.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the price of 114 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person on June 5, 2024. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":447334,"source":{"system":"sec-edgar","filing":"0001193805-24-000768","document":"e663692_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524000768/e663692_4-chivukula.xml","form_type":"4"}},{"id":1491314,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2024-06-04T16:05:45.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":26000,"price":40.009,"value":1040234.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 26,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on June 3, 2024, with sale prices ranging from $40.00 to $40.325 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":447448,"source":{"system":"sec-edgar","filing":"0001193805-24-000746","document":"e663681_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524000746/e663681_4-chivukula.xml","form_type":"4"}},{"id":1559163,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2024-03-27T16:15:32.000Z","date":"2024-03-25","kind":"sale","planned":true,"acquired":false,"shares":17435,"price":35.02,"value":610573.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 17,435 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on March 25, 2024, with sale prices ranging from $35.00 to $35.045 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":473448,"source":{"system":"sec-edgar","filing":"0001193805-24-000452","document":"e663461_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524000452/e663461_4-chivukula.xml","form_type":"4"}},{"id":1564515,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2024-03-21T17:27:19.000Z","date":"2024-03-19","kind":"sale","planned":true,"acquired":false,"shares":8565,"price":35.0075,"value":299839.2375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 8,565 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on March 19, 2024, with sale prices ranging from $35.00 to $35.02 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":490883,"source":{"system":"sec-edgar","filing":"0001193805-24-000426","document":"e619136_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524000426/e619136_4-chivukula.xml","form_type":"4"}},{"id":1704127,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-20T01:01:03.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":75000,"derivative":{"exercise_price":28.88,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001193805-23-001628","document":"e619135_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380523001628/e619135_4-kurata.xml","form_type":"4"}},{"id":1704428,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":76273,"kind":"person","name":"SASSINE ANDY","position":1,"cik":"0001515322","reported_name":"SASSINE ANDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-19T20:01:49.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":75000,"derivative":{"exercise_price":28.88,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001193805-23-001630","document":"e619137_4-sassine.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515322/000119380523001630/e619137_4-sassine.xml","form_type":"4"}},{"id":1704133,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-19T20:01:24.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":125000,"derivative":{"exercise_price":28.88,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001193805-23-001629","document":"e619136_4-chivukula.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001629/e619136_4-chivukula.xml","form_type":"4"}},{"id":1704963,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-19T20:00:44.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":30000,"derivative":{"exercise_price":28.88,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193805-23-001627","document":"e619134_4-kummerfeld.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523001627/e619134_4-kummerfeld.xml","form_type":"4"}},{"id":1704132,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-19T20:00:19.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":200000,"derivative":{"exercise_price":28.88,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001193805-23-001626","document":"e619133_4-payne.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000119380523001626/e619133_4-payne.xml","form_type":"4"}},{"id":1749304,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-11-03T16:30:25.000Z","date":"2023-11-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":18.7203,"value":93601.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on November 1, 2023, with sale prices ranging from $18.39 to $19.27 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":499448,"source":{"system":"sec-edgar","filing":"0001193805-23-001470","document":"e619041_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001470/e619041_4-chivukula.xml","form_type":"4"}},{"id":1764861,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-10-04T16:06:30.000Z","date":"2023-10-02","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":25.6123,"value":128061.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on October 2, 2023, with sale prices ranging from $25.29 to $26.32 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":504448,"source":{"system":"sec-edgar","filing":"0001193805-23-001361","document":"e618979_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001361/e618979_4-chivukula.xml","form_type":"4"}},{"id":1788697,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-09-05T16:05:21.000Z","date":"2023-09-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":31.4527,"value":157263.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on September 1, 2023, with sale prices ranging from $30.70 to $31.75 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":509448,"source":{"system":"sec-edgar","filing":"0001193805-23-001249","document":"e618918_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001249/e618918_4-chivukula.xml","form_type":"4"}},{"id":1803027,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":76273,"kind":"person","name":"SASSINE ANDY","position":1,"cik":"0001515322","reported_name":"SASSINE ANDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-17T17:00:28.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":1223,"price":17.374,"value":21248.402,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person pursuant to the Arcturus Therapeutics Holdings Inc. 2020 Employee Stock Purchase Plan (the \"ESPP\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 16, 2022."}],"balance_after":270526,"source":{"system":"sec-edgar","filing":"0001193805-23-001195","document":"e618886_4-sassine.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515322/000119380523001195/e618886_4-sassine.xml","form_type":"4"}},{"id":1815773,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":30083,"kind":"person","name":"Markels John","position":1,"cik":"0001803424","reported_name":"Markels John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-08-03T20:13:50.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":3131,"derivative":{"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-23-001074","document":"e618812_4-markels.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380523001074/e618812_4-markels.xml","form_type":"4"}},{"id":1815772,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":30083,"kind":"person","name":"Markels John","position":1,"cik":"0001803424","reported_name":"Markels John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-08-03T20:13:50.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":11869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant; provided however, that the remaining unvested balance will vest and become fully exercisable at the Issuer's 2024 annual meeting of stockholders. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":11869,"derivative":{"exercise_price":34.92,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":11869},"source":{"system":"sec-edgar","filing":"0001193805-23-001074","document":"e618812_4-markels.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380523001074/e618812_4-markels.xml","form_type":"4"}},{"id":1816089,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-08-03T20:12:56.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":3131,"derivative":{"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-23-001073","document":"e618811_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380523001073/e618811_4-farrell.xml","form_type":"4"}},{"id":1816088,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-08-03T20:12:56.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":11869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant; provided however, that the remaining unvested balance will vest and become fully exercisable at the Issuer's 2024 annual meeting of stockholders. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":11869,"derivative":{"exercise_price":34.92,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":11869},"source":{"system":"sec-edgar","filing":"0001193805-23-001073","document":"e618811_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380523001073/e618811_4-farrell.xml","form_type":"4"}},{"id":1815771,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38014,"kind":"person","name":"Marantz Jing L.","position":1,"cik":"0001834528","reported_name":"Marantz Jing L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-08-03T20:12:13.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":3131,"derivative":{"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-23-001072","document":"e618810_4-jing.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380523001072/e618810_4-jing.xml","form_type":"4"}},{"id":1815770,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38014,"kind":"person","name":"Marantz Jing L.","position":1,"cik":"0001834528","reported_name":"Marantz Jing L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-08-03T20:12:13.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":11869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant; provided however, that the remaining unvested balance will vest and become fully exercisable at the Issuer's 2024 annual meeting of stockholders. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":11869,"derivative":{"exercise_price":34.92,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":11869},"source":{"system":"sec-edgar","filing":"0001193805-23-001072","document":"e618810_4-jing.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380523001072/e618810_4-jing.xml","form_type":"4"}},{"id":1816075,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38098,"kind":"person","name":"HOLMES EDWARD W","position":1,"cik":"0001197099","reported_name":"HOLMES EDWARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-08-03T20:11:23.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":3131,"derivative":{"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-23-001071","document":"e618809_4-holmes.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197099/000119380523001071/e618809_4-holmes.xml","form_type":"4"}},{"id":1816074,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38098,"kind":"person","name":"HOLMES EDWARD W","position":1,"cik":"0001197099","reported_name":"HOLMES EDWARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-03T20:11:23.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":11869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant; provided however, that the remaining unvested balance will vest and become fully exercisable at the Issuer's 2024 annual meeting of stockholders. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":11869,"derivative":{"exercise_price":34.92,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":11869},"source":{"system":"sec-edgar","filing":"0001193805-23-001071","document":"e618809_4-holmes.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197099/000119380523001071/e618809_4-holmes.xml","form_type":"4"}},{"id":1816087,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38101,"kind":"person","name":"BARLOW JAMES F","position":1,"cik":"0001190637","reported_name":"BARLOW JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-08-03T20:10:34.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":3131,"derivative":{"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-23-001070","document":"e618808_4-barlow.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190637/000119380523001070/e618808_4-barlow.xml","form_type":"4"}},{"id":1816086,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":38101,"kind":"person","name":"BARLOW JAMES F","position":1,"cik":"0001190637","reported_name":"BARLOW JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-08-03T20:10:34.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":11869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant; provided however, that the remaining unvested balance will vest and become fully exercisable at the Issuer's 2024 annual meeting of stockholders. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":11869,"derivative":{"exercise_price":34.92,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":11869},"source":{"system":"sec-edgar","filing":"0001193805-23-001070","document":"e618808_4-barlow.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190637/000119380523001070/e618808_4-barlow.xml","form_type":"4"}},{"id":1815820,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-08-03T20:09:32.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":3131,"derivative":{"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-23-001069","document":"e618807_4-marquet.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000119380523001069/e618807_4-marquet.xml","form_type":"4"}},{"id":1815819,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-08-03T20:09:32.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":11869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant; provided however, that the remaining unvested balance will vest and become fully exercisable at the Issuer's 2024 annual meeting of stockholders. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":11869,"derivative":{"exercise_price":34.92,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":11869},"source":{"system":"sec-edgar","filing":"0001193805-23-001069","document":"e618807_4-marquet.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000119380523001069/e618807_4-marquet.xml","form_type":"4"}},{"id":1815784,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-08-03T16:15:01.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":34.91,"value":174550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on August 1, 2023, with sale prices ranging from $34.44 to $35.70 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":514448,"source":{"system":"sec-edgar","filing":"0001193805-23-001075","document":"e618822_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001075/e618822_4-chivukula.xml","form_type":"4"}},{"id":1827565,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-07-18T18:50:53.000Z","date":"2023-07-14","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":35.01,"value":875250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 25,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on July 14, 2023, with sale prices ranging from $35.00 to $35.04 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":519448,"source":{"system":"sec-edgar","filing":"0001193805-23-001003","document":"e618783_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001003/e618783_4-chivukula.xml","form_type":"4"}},{"id":1827872,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-18T18:50:25.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":false,"shares":1031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":7938,"derivative":{"exercise_price":14.12,"expiration_date":"2030-02-18","underlying":"Common Stock","underlying_shares":1031},"source":{"system":"sec-edgar","filing":"0001193805-23-001002","document":"e618788_4-kummerfeld.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523001002/e618788_4-kummerfeld.xml","form_type":"4"}},{"id":1827871,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-18T18:50:25.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":false,"shares":1437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":7126,"derivative":{"exercise_price":4.99,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":1437},"source":{"system":"sec-edgar","filing":"0001193805-23-001002","document":"e618788_4-kummerfeld.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523001002/e618788_4-kummerfeld.xml","form_type":"4"}},{"id":1827870,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-18T18:50:25.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":21000,"derivative":{"exercise_price":9.04,"expiration_date":"2028-07-04","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001193805-23-001002","document":"e618788_4-kummerfeld.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523001002/e618788_4-kummerfeld.xml","form_type":"4"}},{"id":1827869,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-18T18:50:25.000Z","date":"2023-07-14","kind":"sale","planned":false,"acquired":false,"shares":6968,"price":35,"value":243880.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold in multiple transactions, each at a price of $35.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it on July 14, 2023."}],"balance_after":950,"source":{"system":"sec-edgar","filing":"0001193805-23-001002","document":"e618788_4-kummerfeld.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523001002/e618788_4-kummerfeld.xml","form_type":"4"}},{"id":1827868,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-18T18:50:25.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":true,"shares":1031,"price":14.12,"value":14557.72,"ownership":{"direct":true},"balance_after":7918,"source":{"system":"sec-edgar","filing":"0001193805-23-001002","document":"e618788_4-kummerfeld.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523001002/e618788_4-kummerfeld.xml","form_type":"4"}},{"id":1827867,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-18T18:50:25.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":true,"shares":1437,"price":4.99,"value":7170.63,"ownership":{"direct":true},"balance_after":6887,"source":{"system":"sec-edgar","filing":"0001193805-23-001002","document":"e618788_4-kummerfeld.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523001002/e618788_4-kummerfeld.xml","form_type":"4"}},{"id":1827866,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-18T18:50:25.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":true,"shares":4500,"price":9.04,"value":40680.0,"ownership":{"direct":true},"balance_after":5450,"source":{"system":"sec-edgar","filing":"0001193805-23-001002","document":"e618788_4-kummerfeld.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523001002/e618788_4-kummerfeld.xml","form_type":"4"}},{"id":1832624,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-07-07T06:01:35.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":28.75,"value":143750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on July 3, 2023, with sale prices ranging from $28.57 to $28.96 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":544448,"source":{"system":"sec-edgar","filing":"0001193805-23-000955","document":"e618766_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000955/e618766_4-chivukula.xml","form_type":"4"}},{"id":1866017,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-06-05T16:07:21.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":27.16,"value":135800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on June 1, 2023, with sale prices ranging from $26.87 to $27.54 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":549448,"source":{"system":"sec-edgar","filing":"0001193805-23-000824","document":"e618686_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000824/e618686_4-chivukula.xml","form_type":"4"}},{"id":1894644,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-05-12T16:05:46.000Z","date":"2023-05-11","kind":"sale","planned":true,"acquired":false,"shares":7925,"price":30.24,"value":239652.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 7,925 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on May 11, 2023, with sale prices ranging from $30.035 to $30.48 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":554448,"source":{"system":"sec-edgar","filing":"0001193805-23-000719","document":"e618625_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000719/e618625_4-chivukula.xml","form_type":"4"}},{"id":1894643,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-05-12T16:05:46.000Z","date":"2023-05-10","kind":"sale","planned":true,"acquired":false,"shares":17075,"price":30,"value":512250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 17,075 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on May 10, 2023, with sale prices ranging from $30.00 to $30.06 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":562373,"source":{"system":"sec-edgar","filing":"0001193805-23-000719","document":"e618625_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000719/e618625_4-chivukula.xml","form_type":"4"}},{"id":1905506,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-05-03T16:08:44.000Z","date":"2023-05-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":25.93,"value":129650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions May 1, 2023 with sale prices ranging from $25.39 to $26.58 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":579448,"source":{"system":"sec-edgar","filing":"0001193805-23-000656","document":"e618570_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000656/e618570_4-chivukula.xml","form_type":"4"}},{"id":1917267,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-19T16:57:48.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":false,"shares":1437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":8563,"derivative":{"exercise_price":4.99,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":1437},"source":{"system":"sec-edgar","filing":"0001193805-23-000578","document":"e618515_4-kummerfeld.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523000578/e618515_4-kummerfeld.xml","form_type":"4"}},{"id":1917266,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-19T16:57:48.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":25500,"derivative":{"exercise_price":9.04,"expiration_date":"2028-07-04","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001193805-23-000578","document":"e618515_4-kummerfeld.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523000578/e618515_4-kummerfeld.xml","form_type":"4"}},{"id":1917265,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-19T16:57:48.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":false,"shares":1031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":8969,"derivative":{"exercise_price":14.12,"expiration_date":"2030-02-18","underlying":"Common Stock","underlying_shares":1031},"source":{"system":"sec-edgar","filing":"0001193805-23-000578","document":"e618515_4-kummerfeld.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523000578/e618515_4-kummerfeld.xml","form_type":"4"}},{"id":1917264,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-04-19T16:57:48.000Z","date":"2023-04-18","kind":"sale","planned":false,"acquired":false,"shares":6968,"price":28.18,"value":196358.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.62 to $28.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on April 17, 2023."}],"balance_after":950,"source":{"system":"sec-edgar","filing":"0001193805-23-000578","document":"e618515_4-kummerfeld.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523000578/e618515_4-kummerfeld.xml","form_type":"4"}},{"id":1917263,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-04-19T16:57:48.000Z","date":"2023-04-18","kind":"exercise","planned":false,"acquired":true,"shares":1437,"price":4.99,"value":7170.63,"ownership":{"direct":true},"balance_after":7918,"source":{"system":"sec-edgar","filing":"0001193805-23-000578","document":"e618515_4-kummerfeld.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523000578/e618515_4-kummerfeld.xml","form_type":"4"}},{"id":1917262,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-04-19T16:57:48.000Z","date":"2023-04-18","kind":"exercise","planned":false,"acquired":true,"shares":4500,"price":9.04,"value":40680.0,"ownership":{"direct":true},"balance_after":6481,"source":{"system":"sec-edgar","filing":"0001193805-23-000578","document":"e618515_4-kummerfeld.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523000578/e618515_4-kummerfeld.xml","form_type":"4"}},{"id":1917261,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-04-19T16:57:48.000Z","date":"2023-04-18","kind":"exercise","planned":false,"acquired":true,"shares":1031,"price":14.12,"value":14557.72,"ownership":{"direct":true},"balance_after":1981,"source":{"system":"sec-edgar","filing":"0001193805-23-000578","document":"e618515_4-kummerfeld.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380523000578/e618515_4-kummerfeld.xml","form_type":"4"}},{"id":1924508,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-04-05T20:47:40.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":25.38,"value":126900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions April 3, 2023 with sale prices ranging from $23.56 to $26.12 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":584448,"source":{"system":"sec-edgar","filing":"0001193805-23-000516","document":"e618445_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000516/e618445_4-chivukula.xml","form_type":"4"}},{"id":1962464,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-03-08T21:34:54.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":5000,"price":16.07,"value":80350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions March 6, 2023 with sale prices ranging from $15.66 to $16.09 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":589448,"source":{"system":"sec-edgar","filing":"0001193805-23-000295","document":"e618338_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000295/e618338_4-chivukula.xml","form_type":"4"}},{"id":2081068,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-19T22:02:13.000Z","date":"2022-12-15","kind":"purchase","acquired":true,"shares":2222,"price":18,"value":39996.0,"ownership":{"direct":false,"nature":"Via Alma Life Sciences, LLC"},"balance_after":24942,"source":{"system":"sec-edgar","filing":"0001193805-22-001748","document":"e618133_4-marquet.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000119380522001748/e618133_4-marquet.xml","form_type":"4"}},{"id":2083795,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":96045,"kind":"person","name":"Kummerfeld Keith C","position":1,"cik":"0001762749","reported_name":"Kummerfeld Keith C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-16T18:28:03.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock approved by the Board of Directors on December 9, 2022 pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 9, 2023, the first anniversary of the date this award was approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":40000,"derivative":{"exercise_price":16.92,"expiration_date":"2032-12-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001193805-22-001746","document":"e618136_4-kummerfeld.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1762749/000119380522001746/e618136_4-kummerfeld.xml","form_type":"4"}},{"id":2087397,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":30083,"kind":"person","name":"Markels John","position":1,"cik":"0001803424","reported_name":"Markels John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-12-13T21:10:36.000Z","date":"2022-12-08","kind":"grant","acquired":true,"shares":6986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the annual grant to the Reporting Person as a member of the Board, prorated based on the date the Reporting Person was appointed to the Board, representing an estimated six months of service."}],"balance_after":6986,"derivative":{"exercise_price":18.04,"expiration_date":"2032-12-08","underlying":"Common Stock","underlying_shares":6986},"source":{"system":"sec-edgar","filing":"0001193805-22-001718","document":"e618117_4-markels.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380522001718/e618117_4-markels.xml","form_type":"4"}},{"id":2087396,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":30083,"kind":"person","name":"Markels John","position":1,"cik":"0001803424","reported_name":"Markels John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-12-13T21:10:36.000Z","date":"2022-12-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a two year period from the date of grant. This represents the initial grant to the Reporting Person as a member of the Board of Directors (the \"Board\")."}],"balance_after":20000,"derivative":{"exercise_price":18.04,"expiration_date":"2032-12-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193805-22-001718","document":"e618117_4-markels.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380522001718/e618117_4-markels.xml","form_type":"4"}},{"id":2087395,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-13T21:05:51.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock approved by the Board of Directors on December 9, 2022 pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 9, 2023, the first anniversary of the date this award was approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":125000,"derivative":{"exercise_price":16.92,"expiration_date":"2032-12-09","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001193805-22-001713","document":"e618106_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380522001713/e618106_4-kurata.xml","form_type":"4"}}],"next_cursor":"2022-12-13T21:05:51.000000Z,2087395"}